https://www.selleckchem.com/pr....oducts/asciminib-abl
Thalassemia is characterized by the impaired synthesis of globin chains due to disease-causing variants in α- or β-globin genes. In this review, we provide an overview of the molecular basis underlying α- and β-thalassemia, and of the current technologies used to characterize these disease-causing variants for the diagnosis of thalassemia. Understanding these molecular basis and technologies will prove to be beneficial for the accurate diagnosis of thalassemia.Myelodysplastic syndrome (MDS) refers to a heterogeneous group of cl
Like
Comment
Share
